F
Financials.page
Company Fundamentals
Workspace
OverviewhomeCompaniesdirectoryAPI & MCPdevelopers
Company financial data, refreshed daily. Not investment advice.
Financials.page — company financial data, refreshed daily. Not investment advice. Legal & terms
Annual figures as reported in 10-K / 20-F / 40-F filings.
GWLL · CIK 0001800373

GOLDENWELL BIOTECH, INC.

Annual figures as reported, FY2018–FY2025. Ratios and growth rates derived on-page.

GWLL logo
Food and Kindred Products
Company profile
OTC · GWLLHQ Solon, OHIncorporated in NVFiscal year ends Dec 31Non-accelerated filer Smaller reporting company Emerging growth company
Revenue
$55
▼ −60.4% vs FY2024
Net income
−$296K
▼ −125.5% vs FY2024
Operating cash flow
−$23K
▲ +81.6% vs FY2024
Diluted EPS
$0.00

Revenue

Annual, as reported

020K40K’19’21’23’25$55

Net income

Losses shown in terracotta

−750K−500K−250K0’19’21’23’25−$296K

Recent quarters

momentum · last 12 quarters
Revenue — Mar ’26 quarter
$0
Net income — Mar ’26 quarter
−$18K
▲ +54.3% vs Mar ’25
Revenue — trailing 12 months
$55
▼ −60.4% vs Mar ’25
Diluted EPS — trailing 12 months
$0.00

Quarterly revenue

Discrete quarters; Q4 derived from the annual figure

0100200300Jun ’23Dec ’23Jun ’24Dec ’24Jun ’25Dec ’25Mar ’26$0

Quarterly net income

Losses shown in terracotta

−150K−100K−50K0Jun ’23Dec ’23Jun ’24Dec ’24Jun ’25Dec ’25Mar ’26−$18K
QuarterRevenueRev. YoYGross marginNet incomeNet marginDiluted EPS
Mar ’26$0——−$18K—$0.00
Dec ’25$55—21.8%−$200K−363163.6%$0.00
Sep ’25$0——−$28K——
Jun ’25$0−100.0%—−$30K——
Mar ’25$0−100.0%—−$39K—$0.00
Dec ’24$0−100.0%—−$27K—$0.00
Sep ’24$0−100.0%—−$23K——
Jun ’24$139−49.6%50.4%−$50K−35913.7%—

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

-400000%-200000%0%’21’22’23’24’25
Gross marginOperating marginNet margin

Returns on capital

Net income vs year-end equity and assets

-750%-500%-250%0%’19’21’23’25
Return on equityReturn on assets

Cash flow

cash generation

Operating cash flow

Net cash from operations

−1M−500K0’19’21’23’25−$23K

Shareholder returns

capital allocation

Diluted shares outstanding

Falling count means buybacks outpace dilution

025M50M75M’23’24’2599M

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

0100K’23’24’25−$86K

Net debt

Long-term debt less cash — negative means net cash

050K100K’23’24$125K

Growth rates

compounding, annualized
Revenue CAGR
−89.5%
3y

Key ratios

derived per fiscal year
Fiscal yearGross marginOp. marginNet marginROEROADebt / equity
FY202521.8%−206047.3%−539038.2%—−820.8%—
FY202446.0%−88559.7%−94602.9%−246.8%−58.7%3.27×
FY202328.5%−4949.8%−5015.4%−69.9%−51.5%0.28×
FY202252.7%−2060.9%−2060.9%—−396.6%—
FY202152.5%−740.7%−732.6%—−25.4%—
FY2020————−2.5%—
FY2019————−0.9%—
FY2018——————

Annual figures

as reported
Fiscal yearRevenueGross profitOp. incomeNet incomeDiluted EPSOp. cash flowCapexTotal assetsLiabilitiesEquityCashLT debt
FY2025$55$12−$113K−$296K$0.00−$23K—$36K$380K−$86K$27K—
FY2024$139$64−$123K−$131K$0.00−$123K—$224K$271K$53K$49K$174K
FY2023$2K$666−$116K−$117K$0.00−$113K—$228K$144K$168K$53K$46K
FY2022$48K$25K−$985K−$985K—−$1.1M—$248K$47K—$46K—
FY2021$16K$8K−$118K−$117K$0.00−$205K—$461K$159K—$214K—
FY2020$0$0—−$6K$0.00−$6K—$249K$0—$249K—
FY2019$0$0—−$2K$0.00−$2K—$247K$0—$247K—
FY2018——————————$0—

Latest filings

the most recent regulatory filings
10-QQuarterly report2026-07-01 ↗10-KAnnual report2026-07-01 ↗10-Q/AQuarterly report2026-06-29 ↗10-Q/AQuarterly report2026-06-26 ↗10-Q/AQuarterly report2026-06-26 ↗8-KCurrent report — material event2026-05-27 ↗NT 10-QSEC filing2026-05-12 ↗NT 10-KSEC filing2026-03-31 ↗10-QQuarterly report2025-12-08 ↗10-QQuarterly report2025-09-12 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.